606 related articles for article (PubMed ID: 12796692)
1. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
2. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter.
Kirsch AJ; Perez-Brayfield M; Smith EA; Scherz HC
J Urol; 2004 Jun; 171(6 Pt 1):2413-6. PubMed ID: 15126864
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux.
Perez-Brayfield M; Kirsch AJ; Hensle TW; Koyle MA; Furness P; Scherz HC
J Urol; 2004 Oct; 172(4 Pt 2):1614-6. PubMed ID: 15371773
[TBL] [Abstract][Full Text] [Related]
4. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
[TBL] [Abstract][Full Text] [Related]
5. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.
Molitierno JA; Scherz HC; Kirsch AJ
J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
Kocaoglu C
J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
[TBL] [Abstract][Full Text] [Related]
10. Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children?
Altug U; Cakan M; Yilmaz S; Yalçinkaya F
Pediatr Surg Int; 2007 Jun; 23(6):585-9. PubMed ID: 17356857
[TBL] [Abstract][Full Text] [Related]
11. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies.
Routh JC; Kramer SA; Inman BA; Ashley RA; Wolpert JJ; Vandersteen DR; Husmann DA; Reinberg Y
Urology; 2008 Mar; 71(3):435-8. PubMed ID: 18342182
[TBL] [Abstract][Full Text] [Related]
12. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?
Arlen AM; Scherz HC; Filimon E; Leong T; Kirsch AJ
J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613
[TBL] [Abstract][Full Text] [Related]
13. The deflux procedure reduces the incidence of urinary tract infections in patients with vesicoureteral reflux.
Wadie GM; Tirabassi MV; Courtney RA; Moriarty KP
J Laparoendosc Adv Surg Tech A; 2007 Jun; 17(3):353-9. PubMed ID: 17570788
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic treatment of primary grade V vesicoureteral reflux using hyaluronic acid copolymer (DX/HA).
Hunziker M; Mohanan N; D'Asta F; Puri P
Pediatr Surg Int; 2010 Oct; 26(10):977-9. PubMed ID: 20625750
[TBL] [Abstract][Full Text] [Related]
15. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux?
Routh JC; Inman BA; Ashley RA; Vandersteen DR; Reinberg Y; Wolpert JJ; Kramer SA; Husmann DA
J Pediatr Urol; 2008 Aug; 4(4):260-4. PubMed ID: 18644526
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Subureteral Endoscopic Injection of Dextranomer/Hyaluronic Acid and Lich-Gregoir Ureteral Reimplantation in the Treatment of Pediatric Primary Vesicoureteral Reflux: A Prospective Randomized Study.
Salih EM; Eldamanhory H; Selmy GI; Galal HA
J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):719-723. PubMed ID: 33751917
[No Abstract] [Full Text] [Related]
17. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success.
Lavelle MT; Conlin MJ; Skoog SJ
Urology; 2005 Mar; 65(3):564-7. PubMed ID: 15780377
[TBL] [Abstract][Full Text] [Related]
18. Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates.
Ozok U; Eroglu M; Imamoglu A; Bakirtaş H; Güvence N; Kiper A
J Endourol; 2005 Dec; 19(10):1185-7. PubMed ID: 16359211
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic treatment for vesicoureteral reflux: how important is technique?
Watters ST; Sung J; Skoog SJ
J Pediatr Urol; 2013 Dec; 9(6 Pt B):1192-7. PubMed ID: 23769202
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic Deflux injection for pediatric transplant reflux: a feasible alternative to open ureteral reimplant.
Williams MA; Giel DW; Colleen Hastings M
J Pediatr Urol; 2008 Oct; 4(5):341-4. PubMed ID: 18790416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
